Startup Overview:

Tessera Therapeutics

Tessera Therapeutics is an early-stage life science company pioneering Gene Writing, a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Tessera Therapeutics was founded in 2018 and is based in Cambridge, Massachusetts.

Tessera Therapeutics
Valuation
$
1.69
Billion
Country
United States
City
Cambridge
Industry
Health
Website
Valuation
$
1.69
Billion
Country
United States
City
Cambridge
Industry
Health
Website

Sign-up for our free weekly newsletter to get regular updates when new startups are added.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.